Compare Summit Therapeutics Inc (SMMT) vs Wells Fargo & Co (WFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Summit Therapeutics Inc vs Wells Fargo & Co — how do they compare? Summit Therapeutics Inc trades at $14.57 (market cap $10.48B), while Wells Fargo & Co trades at $87.9 (market cap $261.45B). The key difference: Wells Fargo & Co is far larger — about 24.9× Summit Therapeutics Inc's market cap, and Wells Fargo & Co pays a 2.09% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| SMMT | WFC | |
|---|---|---|
Market Cap | $10.48B | $261.45B |
Sector | Health | Financials |
52-Week High | $29.32 | $96.40 |
52-Week Low | $13.05 | $73.42 |
Enterprise Value | $9.90B | — |
Dividend Yield | — | 2.09% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →About Wells Fargo & Co
Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance sheet assets. The company is split into four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the U.S.
Read more on WFC →
